Please enable JavaScript to continue using this application.

Compare $IDYA vs $VCYT | Chartloom

Compare

$IDYA vs $VCYT

IDEAYA Biosciences Inc · Veracyte Inc

IDYA

IDEAYA Biosciences Inc

VCYT

Veracyte Inc

Compare $IDYA vs $VCYT

Comparing IDEAYA Biosciences Inc and Veracyte Inc

IDYAIDEAYA Biosciences Inc

VCYTVeracyte Inc

IDYAIDEAYA Biosciences Inc

Market cap

$3.43B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

59.38x

Rev growth (TTM)

3244.7%

YTD performance

6.7%

52W performance

34.5%

FCF yield

-3.3%

VCYTVeracyte Inc

Market cap

$3.61B

P/E (TTM)

32.42x

Forward P/E (NTM)

24.66x

Forward P/S (NTM)

5.69x

Rev growth (TTM)

17.3%

YTD performance

6.7%

52W performance

28.9%

FCF yield

4.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IDYA

VCYT

Detailed metrics comparison

IDYA

IDEAYA Biosciences Inc

VCYT

Veracyte Inc

Market Cap

IDYA$3.43B

VCYT$3.61B

Enterprise Value

IDYA$3.16B

VCYT$3.31B

Price

IDYA$36.11

VCYT$45.23

P/E Ratio

IDYAN/A

VCYT32.42x

P/S Ratio

IDYA14.66x

VCYT6.42x

EV/Sales

IDYA13.50x

VCYT5.89x

EV/EBITDA

IDYA0.00x

VCYT24.67x

P/B Ratio

IDYA3.01x

VCYT2.65x

P/FCF Ratio

IDYAN/A

VCYT21.74x

EV/FCF

IDYA-27.76x

VCYT19.94x

PEG Ratio

IDYAN/A

VCYT0.10x

Forward P/E (NTM)

IDYAN/A

VCYT24.66x

Forward P/S (NTM)

IDYA59.38x

VCYT5.69x

Revenue (TTM)

IDYA$234M

VCYT$562M

Revenue Growth (YoY)

IDYA3244.7%

VCYT17.3%

Forward Rev Growth

IDYA218.2%

VCYT11.4%

Gross Margin (TTM)

IDYA0.0%

VCYT71.7%

Operating Margin (TTM)

IDYA0.0%

VCYT19.6%

EBITDA Margin (TTM)

IDYA-91.5%

VCYT22.5%

Net Margin (TTM)

IDYA-74.8%

VCYT20.4%

FCF Margin (TTM)

IDYA-48.6%

VCYT29.5%

Net Income (TTM)

IDYA$-175M

VCYT$114M

FCF (TTM)

IDYA$-114M

VCYT$166M

EPS (TTM)

IDYA-$1.90

VCYT$1.40

ROE (TTM)

IDYA-1647.0%

VCYT8.6%

ROA (TTM)

IDYA-1511.0%

VCYT8.0%

ROIC (TTM)

IDYA-1647.0%

VCYT8.6%

Cash

IDYA$273M

VCYT$300M

Debt

IDYA$0

VCYT$0

Net Cash/Debt

IDYA$273M

VCYT$300M

Current Ratio (TTM)

IDYA10.45x

VCYT9.16x

Quick Ratio (TTM)

IDYA10.21x

VCYT8.60x

Debt/Equity (TTM)

IDYA0.00x

VCYT0.00x

Debt/Assets (TTM)

IDYA0.0%

VCYT0.0%

Interest Coverage (TTM)

IDYAN/A

VCYTN/A

Net Debt/EBITDA (TTM)

IDYA0.00x

VCYT0.00x

Beta

IDYA0.04

VCYT2.00

52W Performance

IDYA34.5%

VCYT28.9%

YTD Performance

IDYA6.7%

VCYT6.7%

% from 52W High

IDYA-15.4%

VCYT-25.7%

% from 52W Low

IDYA38.6%

VCYT53.6%

Asset Turnover (TTM)

IDYA0.20x

VCYT0.39x

FCF Yield (TTM)

IDYA-3.3%

VCYT4.6%

Earnings Yield (TTM)

IDYA-5.1%

VCYT3.2%

Dividend Yield (TTM)

IDYAN/A

VCYTN/A

Rule of 40

IDYA3,196.0

VCYT46.8

EV/GP/RG

IDYAN/A

VCYT0.60

Ticker research

View IDYA research View VCYT research

Metric	IDYA IDEAYA Biosciences Inc	VCYT Veracyte Inc
Market & Valuation
Market Cap	$3.43B	$3.61B
Enterprise Value	$3.16B	$3.31B
Price	$36.11	$45.23
P/E Ratio	N/A	32.42x
P/S Ratio	14.66x	6.42x
EV/Sales	13.50x	5.89x
EV/EBITDA	0.00x	24.67x
P/B Ratio	3.01x	2.65x
P/FCF Ratio	N/A	21.74x
EV/FCF	-27.76x	19.94x
PEG Ratio	N/A	0.10x
Forward P/E (NTM)	N/A	24.66x
Forward P/S (NTM)	59.38x	5.69x
Revenue & Growth
Revenue (TTM)	$234M	$562M
Revenue Growth (YoY)	3244.7%	17.3%
Forward Rev Growth	218.2%	11.4%
Profitability
Gross Margin (TTM)	0.0%	71.7%
Operating Margin (TTM)	0.0%	19.6%
EBITDA Margin (TTM)	-91.5%	22.5%
Net Margin (TTM)	-74.8%	20.4%
FCF Margin (TTM)	-48.6%	29.5%
Net Income (TTM)	$-175M	$114M
FCF (TTM)	$-114M	$166M
EPS (TTM)	-$1.90	$1.40
ROE (TTM)	-1647.0%	8.6%
ROA (TTM)	-1511.0%	8.0%
ROIC (TTM)	-1647.0%	8.6%
Financial Health
Cash	$273M	$300M
Debt	$0	$0
Net Cash/Debt	$273M	$300M
Current Ratio (TTM)	10.45x	9.16x
Quick Ratio (TTM)	10.21x	8.60x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.04	2.00
52W Performance	34.5%	28.9%
YTD Performance	6.7%	6.7%
% from 52W High	-15.4%	-25.7%
% from 52W Low	38.6%	53.6%
Efficiency & Yields
Asset Turnover (TTM)	0.20x	0.39x
FCF Yield (TTM)	-3.3%	4.6%
Earnings Yield (TTM)	-5.1%	3.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	3,196.0	46.8
EV/GP/RG	N/A	0.60
Ticker research	View IDYA research	View VCYT research

Valuation

P/E Ratio

VCYT

32.42x

P/S Ratio

VCYT

6.42x

IDYA

14.66x

EV/FCF

IDYA

-27.76x

VCYT

19.94x

Growth & revenue

Revenue Growth TTM

IDYA

3244.7%

VCYT

17.3%

Forward Revenue Growth

IDYA

218.2%

VCYT

11.4%

Profitability & performance

Gross Margin

VCYT

71.7%

IDYA

0.0%

ROE

VCYT

8.6%

IDYA

-1647.0%

FCF Yield %

VCYT

4.6%

IDYA

-3.3%

52-Week Performance

IDYA

34.5%

VCYT

28.9%

Detailed metrics comparison

IDYA

IDEAYA Biosciences Inc

VCYT

Veracyte Inc

Market Cap

IDYA$3.43B

VCYT$3.61B

Enterprise Value

IDYA$3.16B

VCYT$3.31B

Price

IDYA$36.11

VCYT$45.23

P/E Ratio

IDYAN/A

VCYT32.42x

P/S Ratio

IDYA14.66x

VCYT6.42x

EV/Sales

IDYA13.50x

VCYT5.89x

EV/EBITDA

IDYA0.00x

VCYT24.67x

P/B Ratio

IDYA3.01x

VCYT2.65x

P/FCF Ratio

IDYAN/A

VCYT21.74x

EV/FCF

IDYA-27.76x

VCYT19.94x

PEG Ratio

IDYAN/A

VCYT0.10x

Forward P/E (NTM)

IDYAN/A

VCYT24.66x

Forward P/S (NTM)

IDYA59.38x

VCYT5.69x

Revenue (TTM)

IDYA$234M

VCYT$562M

Revenue Growth (YoY)

IDYA3244.7%

VCYT17.3%

Forward Rev Growth

IDYA218.2%

VCYT11.4%

Gross Margin (TTM)

IDYA0.0%

VCYT71.7%

Operating Margin (TTM)

IDYA0.0%

VCYT19.6%

EBITDA Margin (TTM)

IDYA-91.5%

VCYT22.5%

Net Margin (TTM)

IDYA-74.8%

VCYT20.4%

FCF Margin (TTM)

IDYA-48.6%

VCYT29.5%

Net Income (TTM)

IDYA$-175M

VCYT$114M

FCF (TTM)

IDYA$-114M

VCYT$166M

EPS (TTM)

IDYA-$1.90

VCYT$1.40

ROE (TTM)

IDYA-1647.0%

VCYT8.6%

ROA (TTM)

IDYA-1511.0%

VCYT8.0%

ROIC (TTM)

IDYA-1647.0%

VCYT8.6%

Cash

IDYA$273M

VCYT$300M

Debt

IDYA$0

VCYT$0

Net Cash/Debt

IDYA$273M

VCYT$300M

Current Ratio (TTM)

IDYA10.45x

VCYT9.16x

Quick Ratio (TTM)

IDYA10.21x

VCYT8.60x

Debt/Equity (TTM)

IDYA0.00x

VCYT0.00x

Debt/Assets (TTM)

IDYA0.0%

VCYT0.0%

Interest Coverage (TTM)

IDYAN/A

VCYTN/A

Net Debt/EBITDA (TTM)

IDYA0.00x

VCYT0.00x

Beta

IDYA0.04

VCYT2.00

52W Performance

IDYA34.5%

VCYT28.9%

YTD Performance

IDYA6.7%

VCYT6.7%

% from 52W High

IDYA-15.4%

VCYT-25.7%

% from 52W Low

IDYA38.6%

VCYT53.6%

Asset Turnover (TTM)

IDYA0.20x

VCYT0.39x

FCF Yield (TTM)

IDYA-3.3%

VCYT4.6%

Earnings Yield (TTM)

IDYA-5.1%

VCYT3.2%

Dividend Yield (TTM)

IDYAN/A

VCYTN/A

Rule of 40

IDYA3,196.0

VCYT46.8

EV/GP/RG

IDYAN/A

VCYT0.60

Ticker research

View IDYA research View VCYT research

Metric	IDYA IDEAYA Biosciences Inc	VCYT Veracyte Inc
Market & Valuation
Market Cap	$3.43B	$3.61B
Enterprise Value	$3.16B	$3.31B
Price	$36.11	$45.23
P/E Ratio	N/A	32.42x
P/S Ratio	14.66x	6.42x
EV/Sales	13.50x	5.89x
EV/EBITDA	0.00x	24.67x
P/B Ratio	3.01x	2.65x
P/FCF Ratio	N/A	21.74x
EV/FCF	-27.76x	19.94x
PEG Ratio	N/A	0.10x
Forward P/E (NTM)	N/A	24.66x
Forward P/S (NTM)	59.38x	5.69x
Revenue & Growth
Revenue (TTM)	$234M	$562M
Revenue Growth (YoY)	3244.7%	17.3%
Forward Rev Growth	218.2%	11.4%
Profitability
Gross Margin (TTM)	0.0%	71.7%
Operating Margin (TTM)	0.0%	19.6%
EBITDA Margin (TTM)	-91.5%	22.5%
Net Margin (TTM)	-74.8%	20.4%
FCF Margin (TTM)	-48.6%	29.5%
Net Income (TTM)	$-175M	$114M
FCF (TTM)	$-114M	$166M
EPS (TTM)	-$1.90	$1.40
ROE (TTM)	-1647.0%	8.6%
ROA (TTM)	-1511.0%	8.0%
ROIC (TTM)	-1647.0%	8.6%
Financial Health
Cash	$273M	$300M
Debt	$0	$0
Net Cash/Debt	$273M	$300M
Current Ratio (TTM)	10.45x	9.16x
Quick Ratio (TTM)	10.21x	8.60x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.04	2.00
52W Performance	34.5%	28.9%
YTD Performance	6.7%	6.7%
% from 52W High	-15.4%	-25.7%
% from 52W Low	38.6%	53.6%
Efficiency & Yields
Asset Turnover (TTM)	0.20x	0.39x
FCF Yield (TTM)	-3.3%	4.6%
Earnings Yield (TTM)	-5.1%	3.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	3,196.0	46.8
EV/GP/RG	N/A	0.60
Ticker research	View IDYA research	View VCYT research